Our Clinical Trials

The Sean N. Parker Center for Allergy & Asthma Research at Stanford University conducts many clinical trials with the goal of developing therapies for allergic disorders and asthma.


Participate in Prescreening at the Sean N. Parker Center for Allergy & Asthma at Stanford University

Condition: Allergies, Food Allergies, Asthma, Eczema, Atopic Dermatitis, Allergic Rhinitis, Eosinophilic Esophagitis (EOE)

Age Group: 0-90 y/o

Duration: 1 Time Event

Description: We invite people with doctor-diagnosed food allergies, asthma, eczema, allergic rhinitis, eosinophilic esophagitis (EOE), and other allergic conditions to participate in prescreening for allergy and asthma research at our center.

Contact: If you are interested in learning more about the study or scheduling a prescreening visit, you can call us at (650) 521-7237 or contact us at snpcenterallergy.inquiry@stanford.edu.

OUtMATCH

Study Objectives & Details: Our researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies. Participants must have a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut, or walnut.

Enrollment: This trial is active and currently enrolling.

How to Participate: For more information, call: (650)521-7237 and/or email: snpallergy@stanford.edu

Who Can Participate: Anyone between the ages of 1-55 years who has a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut or walnut.

Gender: Any

Compensation: Provided

Study Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Site Principal Investigator: Dr. Sharon Chinthrajah Study Coordinator: MacKenzie Cox, Laurie Kost

Study Primary Investigator:  Robert Wood, MD

For more information, please click here.

MOTIF Cashew or Shrimp Allergy Study

Condition: Cashew or shrimp allergy

Age Group: 7-55 y/o

Duration: 70 weeks

Description: The purpose of this study is to learn how the shrimp and cashew food allergen affects the immune system and whether analyzing immune cells over time will help us predict if allergies will come back. The study will last 70 weeks and involve 21 clinic visits. Clinic visits include, but are not limited to, a physical examination, blood tests, lung function test, skin prick test, and food challenges. Eligible participants will receive treatment, study-related procedures, and exams at no cost.

Contact: If you are interested in learning more about the study or scheduling a pre-screening visit, you can contact the study coordinator Divya Kumar, at snpallergy@stanford.edu or call us at (650)521-7237.

Wildfires and Health Study        

Condition: With or without preexisting asthma and/or allergies

Age Group: 6-90 years old

The purpose of this study is to understand how wildfire smoke exposure impacts our health. The study is designed to improve our ability to understand and accurately diagnose allergic disease, especially if exposed to wildfire smoke. We hope to learn more about which allergy cells in your body will accurately diagnose allergies and which cells tell us about how severe or persistent a particular allergy is likely to be. Wildfires in California and elsewhere are increasing at an alarming rate and will only get worse with climate change. Little is known about the short-term or long- term health impacts of exposure to wildfire smoke, such as that which infiltrated the Bay Area last Fall.

Matrix II

Condition: Peanut Allergy
Age Group: 
12-17 yo
Duration: 
8.5 months
Description: 
The purpose of this study is to evaluate the safety and tolerability of ASP0892 after intradermal (ID) injection in adolescent participants with peanut allergy. 

Ages Eligible for Study: 12 Years to 17 Years   (Child)

Sexes Eligible for Study: All

Accepts Healthy Volunteers: No

Contact: (650)521-7237 or snpallergy@stanford.edu

MAGIC

Study Objectives & Details: The goal of the clinical trial is to explore whether adding Dupilumab to OIT will enhance the safety and efficacy of OIT in patients with a milk allergy.

Enrollment: This trial is active and currently enrolling.

How to Participate: For more information, call: (650)521-7237 and/or email: snpallergy@stanford.edu

Who Can Participate: 

  • Male or female between 4-50 years of age
  • Diagnosed allergy to cow's milk or milk-containing product
  • If allergic to multiple foods, the participant must eliminate the known food allergens, including milk, from his/her diet so as not to confound the data of the study
  • Willing to comply with the study protocol
  • Willing to participate in all study procedures

 

Our Center will go over additional inclusion and exclusion criteria with participants at the time of screening.

 

Our studies include a wide range of patients, representing a diverse group of ages, ethnicities and socioeconomic backgrounds. Our Center offers equal opportunity to all people with allergies, so long as they are eligible based on study parameters.

JOIN OUR REGISTRY

To participate in our research and be considered for one of our trials

Quick Links

Visit our StudyPages platform to learn more about our clinical trials and studies!